Gain Therapeutics (NasdaqGM:GANX) FY Conference March 24, 2026 01:30 PM ET Company ParticipantsGene Mack - CEOConference Call ParticipantsBoobalan Pachaiyappan - Managing Director and Senior Biotech AnalystBoobalan PachaiyappanGood morning, everyone. My name is Boobalan Pachaiyappan. I'm Managing Director and Senior Biotech Analyst at ROTH Capital Partners. With me today is Gene Mack, who is the Chief Executive Officer of Gain Therapeutics. For those who are new to the story, Gain is focused on developing o ...